10-Q
XBRL
QUARTERLY REPORT
- Company
- Actinium Pharmaceuticals, Inc.
- Filed
- August 13, 2013
- Period of Report
- June 30, 2013
- Accession Number
- 0001213900-13-004217
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →